Overview
PRTA market data
Price History
PRTA price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$4.53 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.34 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $4.32 – $11.80 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $513.6 · P/B 1.83 · P/S 8.86.
Company news
Why Crown Holdings Shares Are Trading Higher; Here Are 20 Stocks Moving PremarketBenzinga · Jul 21, 2026, 9:11 AM
Transthyretin Amyloidosis Treatment Market Size to Reach USD 35.10 Billion by 2035, Growing at a 14.64% CAGR | SNS InsiderGlobenewswire Inc · Jul 7, 2026, 11:15 AM
UPDATED: Watching Prothena; Shares Spike Higher, Form4 Filing Shows William P. Scully Bought 100,000 Shares At An Average Price Of $9.81/ShareBenzinga · May 26, 2026, 7:00 PM
8-K filing — PROTHENA CORP PUBLIC LTD CO (PRTA)SEC EDGAR · May 7, 2026, 8:14 PM